| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/05/2009 | WO2009027650A1 Materials and methods for exploiting synthetic lethality in brca-associated cancers |
| 03/05/2009 | WO2009027644A2 Compositions for the treatment of neoplastic diseases |
| 03/05/2009 | WO2009027641A2 Materials and methods for exploiting synthetic lethality in mismatch repair-deficient cancers |
| 03/05/2009 | WO2009027634A1 Antiseptics |
| 03/05/2009 | WO2009027614A2 Method for splitting omeprazole salts |
| 03/05/2009 | WO2009027604A1 Polycarboxylate phtaleins used as fluorescent dyes and a method for the preparation thereof |
| 03/05/2009 | WO2009027577A1 A combination treatment |
| 03/05/2009 | WO2009027564A1 Use and methods of use for an antagonist of the serotin3 receptor (5-ht3) and a selective modulator of chloride channels for the treatment of addiction to or dependence on medicines/drugs or nervous system disorders |
| 03/05/2009 | WO2009027506A2 Local topical administration formulations containing fipronil |
| 03/05/2009 | WO2009027482A2 Tsh receptor antagonizing tetrahydroquinoline compounds |
| 03/05/2009 | WO2009027475A1 Phenylisoquinoline and phenylquinazoline derivatives for the treatment of bone diseases |
| 03/05/2009 | WO2009027473A1 Combinations of imazalil and hydroxypyridones |
| 03/05/2009 | WO2009027395A1 A new class of histone deacetylase inhibitors |
| 03/05/2009 | WO2009027392A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators |
| 03/05/2009 | WO2009027349A2 Treatment and prevention of neurodegenerative diseases |
| 03/05/2009 | WO2009027346A2 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-dependent diseases |
| 03/05/2009 | WO2009027295A1 3-azabicyclo (4.1.0) heptane derivatives useful as norepinephrine, serotonin or dopamine reuptake inhibitors |
| 03/05/2009 | WO2009027294A1 Substituted azabicyclo [4.1.0] heptane compounds for use as monoamine reuptake inhibitors |
| 03/05/2009 | WO2009027293A1 Compounds |
| 03/05/2009 | WO2009027292A1 Carbonylamino derivatives useful for the treatment of certain inflammatory disorders |
| 03/05/2009 | WO2009027283A1 Triazolopyridine compounds and their use as ask inhibitors |
| 03/05/2009 | WO2009027276A1 Process for the preparation of pyrido [2, 1-a] isoquinoline derivatives and polymorphic froms thereof |
| 03/05/2009 | WO2009027264A1 Benzimidazole derivatives used as fxr agonists |
| 03/05/2009 | WO2009027105A2 Method of providing patient specific immune response in amyloidoses and protein aggregation disorders |
| 03/05/2009 | WO2009027077A2 5-arylalkylidene-2-arylalkyl-thiazol-4-one derivatives as inhibitors of 5-lipoxygenase and uses thereof |
| 03/05/2009 | WO2009027069A2 Osmolytes for the treatment of allergic or viral respiratory diseases |
| 03/05/2009 | WO2009027057A1 Antiviral composition comprising a sulfated polysaccharide |
| 03/05/2009 | WO2009027056A2 Antioxidant and paramagnetic heparin-nitroxide derivatives |
| 03/05/2009 | WO2009027003A1 Use of gestagens in combination with (6s)-5-methyltetrahydrofolate for the therapy of endometriosis with simultaneous reduction of therapy side effects and the reduction of the risk of congenital malformations in case of pregnancy |
| 03/05/2009 | WO2009026940A1 Use of compounds derived from cycloheximide for the treatment or prevention of, in particular, ischaemias and cardiopathies |
| 03/05/2009 | WO2009026935A1 Catecholamine derivatives and prodrugs thereof |
| 03/05/2009 | WO2009026934A1 Catecholamine derivatives useful for the treatment of parkinson' s disease |
| 03/05/2009 | WO2009026858A1 Derivatives of acridinone as anti-parasitic, anti-fungal and anti-viral agents |
| 03/05/2009 | WO2009026837A1 Derivatives of 4,5-disubstituted phenyl-3h-1,2-dithiole-3-thione, -one, -ketoxime and their use |
| 03/05/2009 | WO2009026817A1 Compounds and composition used for inhibitting pge2 released from cmec |
| 03/05/2009 | WO2009026816A1 The application of 1-aryl-2(1h)-pyridone compounds in preparation of medincines for treating itching of the skin |
| 03/05/2009 | WO2009026794A1 Cyclohex-enone compounds from antrodia camphorata for protecting liver |
| 03/05/2009 | WO2009026790A1 Crystal entecavir fomulation and the preparation method thereof |
| 03/05/2009 | WO2009026723A1 Antigenic compositions and use of same in the targeted delivery of nucleic acids |
| 03/05/2009 | WO2009026720A1 Processes and intermediates for preparing fused heterocyclic kinase inhibitors |
| 03/05/2009 | WO2009026717A1 Inhibitors of protein tyrosine kinase activity |
| 03/05/2009 | WO2009026705A1 Method of diagnosing and treating osteoarthritis |
| 03/05/2009 | WO2009026701A1 Sirtuin inhibitors |
| 03/05/2009 | WO2009026697A1 A method of reducing a vasodilatory response using a guanylate cyclase pathway inhibitor or an h2o2 reducing agent |
| 03/05/2009 | WO2009026681A1 Methods of inhibiting tumor growth using beta 5 integrin antagonists |
| 03/05/2009 | WO2009026680A1 Supramacrqmolecular polymer complexes providing controlled nitric oxide release for healing wounds |
| 03/05/2009 | WO2009026658A1 Ppar agonists |
| 03/05/2009 | WO2009026657A1 Flavonoid ppar agonists |
| 03/05/2009 | WO2009026621A1 Pharmaceutical compound & composition |
| 03/05/2009 | WO2009015180A3 Novel compounds and methods of using them |
| 03/05/2009 | WO2009014471A3 Method for producing mechanically activated amorphous and amorphocrystalline compounds of gluconic acid calcium salt |
| 03/05/2009 | WO2009012242A3 Sodium channel inhibitors |
| 03/05/2009 | WO2009011889A3 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| 03/05/2009 | WO2009011850A3 Novel therapeutic compounds |
| 03/05/2009 | WO2009010479A3 Heterocyclic methylene piperidine derivatives and their use |
| 03/05/2009 | WO2009010477A8 Piperidine-4-acetic acid derivatives and their use |
| 03/05/2009 | WO2009010455A3 Pyrazole derivatives as modulators of metabotropic glutamate receptors |
| 03/05/2009 | WO2009010454A3 Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 03/05/2009 | WO2009010416A3 Inhibitors of 11b-hydroxysteroid dehydrogenase |
| 03/05/2009 | WO2009010298A8 Paullone derivatives and its use |
| 03/05/2009 | WO2009009393A3 Chromium complexes for improvement of memory and cognitive function |
| 03/05/2009 | WO2009008905A4 Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning |
| 03/05/2009 | WO2009008683A3 Multi-layered vitamin complex tablet containing ubidecarenone |
| 03/05/2009 | WO2009008009A4 Novel crystalline form b of carvedilol dihydrogen phosphate |
| 03/05/2009 | WO2009008004A3 Sustained release formulations of divalproex sodium |
| 03/05/2009 | WO2009007996A3 Cyclodextrin complexes of atovaquone |
| 03/05/2009 | WO2009007808A4 Combined pharmaceutical composition |
| 03/05/2009 | WO2009007747A3 Hydantoin derivatives used as mmp12 inhibitors |
| 03/05/2009 | WO2009007454A3 8-beta-substituted estratrienes as selectively active estrogens |
| 03/05/2009 | WO2009006431A3 Biologically active aphrocallistin compounds |
| 03/05/2009 | WO2009005690A3 Antiviral compounds |
| 03/05/2009 | WO2009005677A3 Antiviral compounds |
| 03/05/2009 | WO2009005676A3 Antiviral compounds |
| 03/05/2009 | WO2009004382A3 3-spiropyrimidinetrione-quinoline derivatives and their use as antibacterial agents |
| 03/05/2009 | WO2009003090A9 Compositions and methods for inhibiting viral and bacterial activity |
| 03/05/2009 | WO2009001356A3 Acyl-urea derivatives and uses thereof |
| 03/05/2009 | WO2008157291A3 CRYSTALLINE FORMS OF (3Aα, 4β, 5α, 7β, 7Aα)-4-(OCTAHYDRO-5-ETHYLSULFONAMIDO-4,7-DIMETHYL-1,3-DIOXO-4,7-EPOXY-2H-ISOINDOL-2-YL)-2-(TRIFLUOROMETHYL)BENZONITRILE AND METHOD OF PREPARATION |
| 03/05/2009 | WO2008156828A8 Renin inhibitors |
| 03/05/2009 | WO2008156817A8 Renin inhibitors |
| 03/05/2009 | WO2008156816A8 Renin inhibitors |
| 03/05/2009 | WO2008152334A3 Novel derivatives of 3-phenyl acrylic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions |
| 03/05/2009 | WO2008149035A3 Novel active ingredient in cicatrization and use thereof |
| 03/05/2009 | WO2008148868A8 Piperidine/piperazine derivatives |
| 03/05/2009 | WO2008148849A8 Piperidine/piperazine derivatives |
| 03/05/2009 | WO2008148754A3 Macrocycles and their uses |
| 03/05/2009 | WO2008147557A3 Heteroaryl substituted thiazoles and their use as antiviral agents |
| 03/05/2009 | WO2008145681A3 Ccr2 receptor antagonists and uses thereof |
| 03/05/2009 | WO2008142720A4 Quinazolin-oxime derivatives as hsp90 inhibitors |
| 03/05/2009 | WO2008142463A3 Carbamoyl-cyclohexanes for treating acute mania |
| 03/05/2009 | WO2008139263A3 Methods for slowing the progression of multiple sclerosis |
| 03/05/2009 | WO2008138591A3 Bicyclic and heterobicyclic derivatives,processes for preparing them and their uses |
| 03/05/2009 | WO2008138448A3 Heterocyclic indazole derivatives |
| 03/05/2009 | WO2008137622A3 Aminopyrimidines useful as kinase inhibitors |
| 03/05/2009 | WO2008131502A3 Antiviral compounds of the adamantane type |
| 03/05/2009 | WO2008131411A3 Stimulating neuronal growth using brevetoxins |
| 03/05/2009 | WO2008129157A4 Amorphous solid composition containing a pyrazole-3-carboxamide in amorphous form and stabilising carriers |
| 03/05/2009 | WO2008128115A3 Low-dose doxepin formulations |
| 03/05/2009 | WO2008127274A3 Heterocyclic inhibitors of bacterial peptidyl trna hydrolase and uses thereof |
| 03/05/2009 | WO2008115319A3 Conjugates of synthetic tlr agonists and uses therefor |
| 03/05/2009 | WO2008110846A3 Compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases |